Replies to post #126757 on Biotech Values

[pcrutch]

I agree that something seems fishy about "pending review of labeling matters"... If it was fully substitutable, then no need for labeling discussions, right?

[HattieTheWitch]

Reviews of generic drugs do not typically have labeling discussions insofar as the label of the generic is typically identical to the label of the corresponding branded drug.

Maybe Amphastar has been studying TEVA's PR methods? ;-)

[dav1234]

why has WPI not issued any news on this "material event"